Search Details

Word: hb (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...HB: Me and Shawn knew each other first. We were roommates in junior year and last year lived off campus. The idea for this band started a little more than a year ago. We had been jamming for a while, and we decided to take this to a greater level, and we thought that David Horn was the perfect addition...

Author: By Daryl Sng, CRIMSON STAFF WRITER | Title: What's My Number? | 12/17/1999 | See Source »

...into the field. Trusted brands like Bayer's One-A-Day and well-known companies such as Warner-Lambert (Sudafed, Benadryl and Listerine) and the Whitehall-Robins Healthcare unit of American Home Products (Centrum, Advil, Robitussin) all launched brightly packaged lines of herbal remedies this fall. SmithKline Beecham (Tagamet HB, Contac, NicoDerm CQ) test marketed herbs in four U.S. cities last summer. The entry of these brands and the growing body of serious research on herbal remedies are lifting some of the stigma attached to these products--and cutting through some of the claptrap one can still hear about mystical...

Author: /time Magazine | Title: Herbal Healing | 11/23/1998 | See Source »

...outdone, J&J/Merck countersued in September, charging SmithKline with "false advertising" and asking for "corrective advertising and punitive and actual damages." Their suit noted, for example, that SmithKline falsely claimed that Tagamet HB and SmithKline's Tums work faster, and that doctors prefer Tagamet HB to Pepcid...

Author: /time Magazine | Title: FIRE IN THE BELLY, MONEY IN THE BANK | 11/6/1995 | See Source »

...firms in the fray or about to enter it are only too aware that their new heartburn drugs are bound to cannibalize their traditional antacid products. In touting Tagamet HB, for example, SmithKline has to avoid invidious comparisons with Tums, its antacid moneymaker, while J&J/Merck must tiptoe around any comparisons between Pepcid AC and its antacid, the much advertised Mylanta. Meanwhile, Switzerland's Ciba-Geigy has other worries. Though it has no acid blocker available that could bite into sales of Maalox, its bread-and-butter antacid, its competitors' new drugs almost certainly will...

Author: /time Magazine | Title: FIRE IN THE BELLY, MONEY IN THE BANK | 11/6/1995 | See Source »

Though hurt by the onslaught of acid blockers, the lower-priced and faster-acting antacids will almost certainly maintain a respectable market share. Tums, for example, costs less than 3¢ a tablet. That compares with more than 40¢ for a one-a-day Pepcid AC tablet or a Tagamet HB two-tablet dose, although both products currently offer substantial rebates. Still, booming sales of the new acid blockers seem to show that heartburn sufferers are not troubled by sticker shock. At a Duane Reade drugstore in Manhattan, Darlene Jackson, 35, picked up a box of Tagamet HB and noted...

Author: /time Magazine | Title: FIRE IN THE BELLY, MONEY IN THE BANK | 11/6/1995 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next